- Home
- DCTH vs TRC Comparison
DCTH vs TRC Comparison
Compare DCTH & TRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- TRC
- Stock Information
- Founded
- DCTH 1988
- TRC 1843
- Country
- DCTH United States
- TRC United States
- Employees
- DCTH N/A
- TRC N/A
- Industry
- DCTH Medical/Dental Instruments
- TRC Real Estate
- Sector
- DCTH Health Care
- TRC Finance
- Exchange
- DCTH Nasdaq
- TRC Nasdaq
- Market Cap
- DCTH 388.3M
- TRC 419.0M
- IPO Year
- DCTH N/A
- TRC N/A
- Fundamental
- Price
- DCTH $8.62
- TRC $15.80
- Analyst Decision
- DCTH Strong Buy
- TRC
- Analyst Count
- DCTH 5
- TRC 0
- Target Price
- DCTH $22.60
- TRC N/A
- AVG Volume (30 Days)
- DCTH 1.3M
- TRC 86.1K
- Earning Date
- DCTH 11-04-2025
- TRC 11-06-2025
- Dividend Yield
- DCTH N/A
- TRC N/A
- EPS Growth
- DCTH N/A
- TRC N/A
- EPS
- DCTH 0.03
- TRC 0.11
- Revenue
- DCTH $79,603,000.00
- TRC $46,420,000.00
- Revenue This Year
- DCTH $135.11
- TRC N/A
- Revenue Next Year
- DCTH $36.30
- TRC N/A
- P/E Ratio
- DCTH $250.39
- TRC $142.19
- Revenue Growth
- DCTH 251.54
- TRC 15.71
- 52 Week Low
- DCTH $8.39
- TRC $14.71
- 52 Week High
- DCTH $18.23
- TRC $19.39
- Technical
- Relative Strength Index (RSI)
- DCTH 30.11
- TRC 47.21
- Support Level
- DCTH $9.15
- TRC $15.44
- Resistance Level
- DCTH $10.03
- TRC $16.00
- Average True Range (ATR)
- DCTH 0.67
- TRC 0.35
- MACD
- DCTH -0.21
- TRC 0.04
- Stochastic Oscillator
- DCTH 5.71
- TRC 45.70
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About TRC Tejon Ranch Co
Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely Real Estate - Commercial/Industrial, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.